disease progression

Posted on Monday, October 1, 2007 - 09:16, By: Margaret Wahl
In January, MDA announced a new strategic partnership with the ALS Therapy Development Institute in Cambridge, Mass., to identify molecular targets for drug development and to screen potential therapeutic agents for ALS treatment. MDA, through its fast-track ALS research initiative, Augie’s...